Oncology & Cancer

Genetically engineering a treatment for incurable brain tumors

Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional ...

Oncology & Cancer

Expert reviews the current state of retinoblastoma research

Retinoblastoma is a rare pediatric cancer, with approximately 250–300 new cases per year in the United States and 8,000 worldwide. The cancer grows within the retina, a thin layer of cells at the back of the eye, and is ...

Oncology & Cancer

Using AI to trace the origins of metastatic cancer cells

A large team of cancer researchers affiliated with several institutions in China, working with a pair of colleagues in the U.S., has found that artificial intelligence applications can be used to trace the origins of metastatic ...

page 5 from 27